Neubase Therapeutics Inc. (NBSE)

Market is closed

Insider Trading: Purchases

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Backenroth Officer	$3.22	11	$35.42	136,373	2016-05-23	Filing
Backenroth Officer	$3.23	163	$526.49	136,362	2016-05-23	Filing
Slakter Officer, Director	$3.35	6,250	$20,937.50	884,504	2016-04-11	Filing
Slakter Officer, Director	$3.41	100	$341.00	878,254	2016-03-07	Filing
Slakter Officer, Director	$3.44	100	$344.00	878,154	2016-03-07	Filing
Slakter Officer, Director	$3.46	200	$692.00	878,054	2016-03-07	Filing
Slakter Officer, Director	$3.49	100	$349.00	877,854	2016-03-07	Filing
Slakter Officer, Director	$3.50	100	$350.00	877,754	2016-03-07	Filing
Slakter Officer, Director	$3.55	100	$355.00	877,654	2016-03-07	Filing
Slakter Officer, Director	$3.57	100	$357.00	877,554	2016-03-07	Filing
Slakter Officer, Director	$3.58	100	$358.00	877,454	2016-03-07	Filing
Slakter Officer, Director	$3.59	100	$359.00	877,354	2016-03-07	Filing
Slakter Officer, Director	$3.60	400	$1,440.00	877,254	2016-03-07	Filing
Slakter Officer, Director	$3.61	300	$1,083.00	876,854	2016-03-07	Filing
Slakter Officer, Director	$3.63	2,200	$7,986.00	876,554	2016-03-07	Filing
Slakter Officer, Director	$3.64	200	$728.00	874,354	2016-03-07	Filing
Slakter Officer, Director	$3.65	300	$1,095.00	874,154	2016-03-07	Filing
Slakter Officer, Director	$3.66	327	$1,196.82	873,854	2016-03-07	Filing
Slakter Officer, Director	$3.70	1,523	$5,635.10	873,527	2016-03-07	Filing
Slakter Officer, Director	$3.06	200	$612.00	872,004	2016-02-22	Filing